⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

SOLV

Solventum Corporation

Healthcare · Medical Instruments & Supplies

90.03USD

-0.0800 (-0.09%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$1.35▼$1.43110
Next quarter$1.79▲$1.7772
Current year$7.14▲$6.55140
Next year$7.22▲$7.05113

Recent quarters

Beat in 4 of the last 4

QuarterEstimateActualSurprise
2026-06-30$1.91$2.55+0.64 (+33.8%)
2026-03-31$1.35$1.48+0.13 (+9.3%)
2025-12-31$1.5$1.57+0.07 (+5.0%)
2025-09-30$1.43$1.5+0.07 (+4.7%)

Wall Street coverage

60 ratings from 17 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
UBSMaintainedBuy$95 $101Aug 6, 2026
Piper SandlerMaintainedOverweight$92 $105Aug 6, 2026
WedbushMaintainedOutperform$94 $101Aug 6, 2026
KeybancMaintainedOverweight$93 $102Aug 6, 2026
StifelMaintainedBuy$90 $100Aug 6, 2026
BTIGMaintainedBuy$91 $95Aug 6, 2026
UBSUpgraded from NeutralBuy$95Jul 28, 2026
BMO CapitalInitiatedMarket Perform$81Jul 9, 2026
WedbushInitiatedOutperform$94May 15, 2026
UBSMaintainedNeutral$82 $78May 6, 2026
StifelMaintainedBuy$105 $90May 6, 2026
Wells FargoMaintainedEqual-Weight$83 $70May 6, 2026
KeybancMaintainedOverweight$92 $93May 6, 2026
BTIGReiteratedBuy$89May 6, 2026
KeybancMaintainedOverweight$99 $92Apr 27, 2026
Piper SandlerMaintainedOverweight$98 $92Apr 17, 2026
Rothschild & CoInitiatedSell$60Mar 24, 2026
Wells FargoMaintainedEqual-Weight$86 $83Feb 27, 2026
KeybancMaintainedOverweight$97 $99Feb 27, 2026
BTIGReiteratedBuy$100Feb 27, 2026
KeybancUpgraded from Sector WeightOverweight$97Jan 26, 2026
MizuhoUpgraded from NeutralOutperform$85 $100Jan 20, 2026
StifelMaintainedBuy$88 $105Jan 7, 2026
BTIGUpgraded from NeutralBuy$100Dec 2, 2025
UBSMaintainedNeutral$77 $79Nov 10, 2025

Insider transactions

72 filings from 22 insiders · 0 buy / 0 sell over 6m

Officers and directors of SOLV, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
Hanson Bryan CDirector; Officer, Chief Executive OfficerExerciseRestricted Stock Units67.3k——Sep 1, 2026
Hanson Bryan CDirector; Officer, Chief Executive OfficerTax26.5k$90.95$2.41MSep 1, 2026
Hanson Bryan CDirector; Officer, Chief Executive OfficerExercise67.3k——Sep 1, 2026
MCMILLAN WAYDE DChief Financial OfficerOther9.5k——May 13, 2026
HANSON BRYAN CRAIGChief Executive OfficerOther34.3k——May 13, 2026
KIRBERGER MARCELA A.OfficerOther4.5k——May 13, 2026
GOMEZ TAMMY LOfficerOther4.0k——May 13, 2026
LANDUCCI AMYChief Technology OfficerOther4.4k——May 13, 2026
WILCOX MARY TOfficerOther2.4k——May 13, 2026
HARRINGTON PAUL SOfficerOther4.0k——May 13, 2026
ALBAN CARLOSDirectorOther3.4k——Apr 30, 2026
DEVORE SUSAN DDirectorOther3.4k——Apr 30, 2026
WILSON DARRYL LDirectorOther3.4k——Apr 30, 2026
MILY ELIZABETHDirectorOther3.4k——Apr 30, 2026
EDWARDS SHIRLEY ANNDirectorOther3.4k——Apr 30, 2026
WEILAND JOHN HDirectorOther3.4k——Apr 30, 2026
COX CARRIE SMITHDirectorOther4.9k——Apr 30, 2026
MAY KAREN JDirectorOther3.4k——Apr 30, 2026
EISENBERG GLENN ADirectorOther3.4k——Apr 30, 2026
HARRIS BERNARD A JRDirectorOther3.4k——Apr 30, 2026

Analyst Notes

Sign in to write

No analyst notes on SOLV yet.

Analyst Ratings

13 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current17511Hold2.60
1 mo ago17511Hold2.60
2 mo ago17511Hold2.60
3 mo ago16521Hold2.73
Price target$93.92$70.00 – $113.00
+4.3% to target